SEC Form 4 · accession 0001140361-15-044434
BLONDER TONGUE LABORATORIES INC · BDR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Robert J Palle Jr.
Officer — President and CEO · Director · 10% Owner
Period of report
Dec 10, 2015
Accepted (ET)
Dec 14, 2015 · 4:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001000683
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2,F1,F3 | $0.395 | Dec 10, 2015 | A | 250,000 | A | — | Dec 10, 2025 | Common Stock, par value $0.001 | 250,000 | 250,000 | D |
Explanation of responses
- F1The exercise price equals the fair market value (equal to the average of the high and low selling prices as reported on the NYSE MKT) of the common stock on the grant date.
- F2The stock option was granted under the 2005 Employee Equity Incentive Plan, as amended and restated.
- F3The stock option vests in three equal installments of one-third each on the first, second and third anniversary of the date of grant.